Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease

Journal of Interventional Cardiology

Volumn 20, Issue 1, 2007, Pages 10-16

  Yang, Zhen Kun ^a   Shen, Wei Feng ^a   Zhang, Rui Yan ^a   Kong, Ye ^a   Zhang, Jian Sheng ^a   Hu, Jian ^a   Zhang, Qi ^a   Ding, Feng Hua ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IMPLANTATION; INCIDENCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REOPERATION; REVASCULARIZATION; STROKE; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD VESSEL PROSTHESIS IMPLANTATION; CHINA; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; CORONARY RESTENOSIS; DISEASE-FREE SURVIVAL; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; LENGTH OF STAY; MALE; OUTCOME ASSESSMENT (HEALTH CARE); SEVERITY OF ILLNESS INDEX; STENTS; SURVIVAL ANALYSIS;

EID: 33846510300     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2007.00222.x     Document Type: Article

References (20)

1. Gaziano JM. Global burden of cardiovascular disease. InZipes D, Libby P, Bonow RO, Braunwald E, editors. Heart Disease. A Textbook of Cardiovascular Medicine. 7th ed. Philadelphia: WB Saunders, 2005, pp. 1-19.
2. Serruys PW, Unger F, Sousa JE, et al. Comparison of coronary artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001;344:1117-1124.
3. SoS Investigators. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): A randomized controlled trial. Lancet 2002;360:965-970.
4. Rodriguez A, Bernardi V, Navia J, et al. Argentine randomized study: Coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30-Day and one-year follow-up results. ERACI II Investigators. J Am Coll Cardiol 2001;37:51-58.
5. Morrison DA, Sethi G, Sacks J, et al. Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: A multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME). J Am Coll Cardiol 2001;38:143-149.
6. Hueb W, Soares PR, Gersh BJ, et al. The Medicine, Angioplasty, or Surgery Study (MASS-II): A randomizes, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease. J Am Coll Cardiol 2004;43:1743-1751.
7. Klein LW. Are drug-eluting stents the preferred treatment for multivessel coronary artery disease? J Am Coll Cardiol 2006;47:22-26.
8. Greenland S, Robins JM. Estimation of a common effect parameter from sparse follow-up data. Biometrics 1985;41:55-68.
9. Serruys PW, Ong AT, van Herwerden LA, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: The final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 2005;46:575-581.
10. Mercado N, Wijns W, Serruys PW, et al. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: A meta-analysis of individual patient data from randomized clinical trials. J Thorac Cardiovasc Surg 2005;130:512-519.
11. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323.
12. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;250:221-231.
13. Arampatzis CA, Hoye A, Lemos PA, et al. Elective sirolimus-eluting stent implantation for multivessel disease involving significant LAD stenosis: One-year clinical outcomes of 99 consecutive patients - The Rotterdam experience. Catheter Cardiovasc Interv 2004;63:57-60.
14. Orlic D, Bonizzoni E, Stankovic G, et al. Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: Immediate and mid-term results. J Am Coll Cardiol 2004;43:1154-1160.
15. Lemos PA, Serruys PW, van Domburg RT, et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": The Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Registry. Circulation 2004;109:190-195.
16. Ong AT, Serruys PW, Aoki J, et al. The unrestricted use of paclitaxel versus sirolimus-eluting stents for coronary artery disease in an unselected population - One Year Results of The Taxus-Stent Evaluated At Rotterdam Cardiology Hospital (T-SEARCH) Registry. J Am Coll Cardiol 2005;45:1135-1141.
17. Serruys PW. ARTS II. Arterial Revascularization Therapies Study part II of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. EuroInterv 2005;1:147-156.
18. Glaser R, Selzer F, Faxon DP, et al. Clinical progression of incidental, asymptomatic lesions discovered during culprit vessel coronary intervention. Circulation 2005;111:143-149.
19. LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005;352:1425-35.
20. Nissen SE, Nicholls SJ, Sipahi I, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: The ASTEROID trial. JAMA 2006;295:1556-65.